Sales of vaccines from Pfizer and Moderna exceeded $56 billion last year; analysts anticipate only $20 billion this year

A new COVID vaccine is scheduled to be released next month, but analysts and health professionals predict that it will likely be met with scepticism even as hospitalizations from “Eris,” a coronavirus variant of the Omicron form, surge across the…